Peripheral complement C3 and C4 are associated with clinical features of schizophrenia. [PDF]
Szwajca M +5 more
europepmc +1 more source
Hypertension in Living Kidney Donors Has No Effect on Complement Activation and Fibrosis.
Wagner N +7 more
europepmc +1 more source
Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum. [PDF]
Kotnik N +10 more
europepmc +1 more source
Pegcetacoplan for the Treatment of Paediatric C3 Glomerulonephritis: A Case Report. [PDF]
Guzman GL, Perry KW.
europepmc +1 more source
Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia. [PDF]
Myoung SS +9 more
europepmc +1 more source
Complement-Mediated Kidney Diseases: Role of Alternative Pathway in Glomerular Inflammation. [PDF]
Barratt J +4 more
europepmc +1 more source
Bone impairment in atypical hemolytic and uremic syndrome treated by long-term eculizumab. [PDF]
Regnier M +7 more
europepmc +1 more source
Activation of the alternative complement pathway and its relevance for sodium retention in experimental nephrotic syndrome. [PDF]
Essigke D +10 more
europepmc +1 more source
Dual inflammation in schizophrenia infected with COVID-19: Impact on cognitive function. [PDF]
Zhou Q +10 more
europepmc +1 more source

